Ready-to-use food (RUF) is increasingly used for nutritional therapy in HIV-infected individuals. However, practical guidance advising nutrition care to HIV-infected adolescents is lacking, so that little is known about the acceptability of such therapy in this vulnerable population.

This study assesses the overall acceptability and perception of a RUF-based therapy and risk factors associated with sub-optimal RUF intake in HIV-infected undernourished adolescents in Senegal.Participants 5 to 18 years of age with acute malnutrition were enrolled in 12 HIV clinics in Senegal. Participants were provided with imported RUF, according to WHO prescription weight- and age-bands (2009), until recovery or for a maximum of 9-12 months. Malnutrition and recovery were defined according to WHO growth standards.

Adherence was assessed fortnightly by self-reported RUF intake over the period. Sub-optimal RUF intake was defined as when consumption of the RUF provision was < 50%. RUF therapy acceptability and perceptions were assessed using a structured questionnaire at week 2 and focus group discussions (FGDs) at the end of the study. Factors associated with sub-optimal RUF intake at week 2 were identified using a stepwise logistic regression model.

We enrolled 173 participants, with a median age of 12.5 years (Interquartile range: 9.5-14.9), of whom 61% recovered from malnutrition within the study period.

Median follow-up duration was 66 days (21-224). RUF consumption was stable, varying between 64 and 57% of the RUF provided, throughout the follow-up. At week 2, sub-optimal RUF intake was observed in 31% of participants. Dislike of the taste of RUF (aOR = 5.0, 95% CI: 2.0-12.3), HIV non-disclosure (5.1, 1.9-13.9) and food insecurity (2.8, 1.1-7.2) were the major risk factors associated with sub-optimal RUF intake at week 2.

CD57 / B3GAT1 (Natural Killer Cell Marker); Clone NK-1 (Concentrate)

RA0356-C.1 ScyTek Laboratories 0.1 ml 60.07 EUR

CD57 / B3GAT1 (Natural Killer Cell Marker); Clone NK-1 (Concentrate)

RA0356-C.5 ScyTek Laboratories 0.5 ml 158.6 EUR

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody, Clone: NK/804

AMM00761G Leading Biology 7 ml 580.8 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker). The antibodies are raised in Mouse and are from clone NK/804. This antibody is applicable in IHC, IF

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody, Clone: NK-1

AMM00752G Leading Biology 7 ml 580.8 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker). The antibodies are raised in Mouse and are from clone NK-1. This antibody is applicable in IHC, IF

293AD Cell Line

AD-100 Cell Biolabs 1 vial 365 EUR

293AAV Cell Line

AAV-100 Cell Biolabs 1 vial 405 EUR

293LTV Cell Line

LTV-100 Cell Biolabs 1 vial 405 EUR

293RTV Cell Line

RV-100 Cell Biolabs 1 vial 405 EUR

StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible)

CBA-325 Cell Biolabs 96 assays 1027.2 EUR
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis.

StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible)

CBA-325-5 Cell Biolabs 5 x 96 assays 4033.2 EUR
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis.

CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Colorimetric

CBA-135 Cell Biolabs 96 assays 715 EUR

CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Colorimetric

CBA-135-5 Cell Biolabs 5 x 96 assays 3095 EUR

CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Fluorometric

CBA-140 Cell Biolabs 96 assays 750 EUR

CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Fluorometric

CBA-140-5 Cell Biolabs 5 x 96 assays 3215 EUR

CD57 / B3GAT1 (Natural Killer Cell Marker); Clone HNK-1 & NK-1 (Concentrate)

RA0357-C.1 ScyTek Laboratories 0.1 ml 60.07 EUR

CD57 / B3GAT1 (Natural Killer Cell Marker); Clone HNK-1 & NK-1 (Concentrate)

RA0357-C.5 ScyTek Laboratories 0.5 ml 158.6 EUR

293/GFP Cell Line

AKR-200 Cell Biolabs 1 vial 460 EUR

T47D/GFP Cell Line

AKR-208 Cell Biolabs 1 vial 686.4 EUR
Description: T47D/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line.

A549/GFP Cell Line

AKR-209 Cell Biolabs 1 vial 460 EUR

HeLa/GFP Cell Line

AKR-213 Cell Biolabs 1 vial 460 EUR

293/Cas9 Cell Line

AKR-5110 Cell Biolabs 1 vial 460 EUR

HeLa/Cas9 Cell Line

AKR-5111 Cell Biolabs 1 vial 460 EUR

NIH3T3/GFP Cell Line

AKR-214 Cell Biolabs 1 vial 460 EUR

NIH3T3/Cas9 Cell Line

AKR-5104 Cell Biolabs 1 vial 460 EUR

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC041259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405S conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC041259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405S conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC881259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF488A conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC881259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF488A conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC801259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC801259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC811259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC811259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC941259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC941259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC431259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF543 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC431259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF543 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC401259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF640R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC401259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF640R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC471259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF647 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC471259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF647 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC051259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405M conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC051259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405M conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC551259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF555 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC551259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF555 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC701259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF770 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC701259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF770 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC611259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF660R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC611259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF660R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC681259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF568 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC681259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF568 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCP1259-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), PerCP conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCR1259-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), RPE conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNUB1259-100 Biotium 100uL 250.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Concentration: 0.2mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNUB1259-500 Biotium 500uL 549.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Concentration: 0.2mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCA1259-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), APC conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCH1259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCH1259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCAP1259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCAP1259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCB1259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Biotin conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCB1259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Biotin conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNUM1259-50 Biotium 50uL 474 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), 1mg/mL

CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric, Trial Size

CBA-135-T Cell Biolabs 24 assays 518.4 EUR
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis.

MCF-7/Luc Cell Line

AKR-234 Cell Biolabs 1 vial 686.4 EUR
Description: MCF-7/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line.

SKOV-3/Luc Cell Line

AKR-232 Cell Biolabs 1 vial 686.4 EUR
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line.

OVCAR-5/RFP Cell Line

AKR-254 Cell Biolabs 1 vial 686.4 EUR
Description: OVCAR-5/RFP Cell Line stably expresses RFP and otherwise exhibits the same characteristics of the parental cell line.

CytoSelect 96-Well Cell Transformation Assay (Cell Recovery Compatible, Fluorometric), Trial Size

CBA-140-T Cell Biolabs 24 assays 547.2 EUR
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis.

Collagen-based Cell Contraction Assay

CBA-201 Cell Biolabs 24 assays 420 EUR

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody, Clone: HNK-1 + NK-1

AMM00758G Leading Biology 7 ml 580.8 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker). The antibodies are raised in Mouse and are from clone HNK-1 + NK-1. This antibody is applicable in IHC, IF

Radius 384-Well Cell Migration Assay

CBA-127 Cell Biolabs 384 assays 721.2 EUR
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap.

Radius 384-Well Cell Migration Assay

CBA-127-5 Cell Biolabs 5 x 384 wells 2802 EUR
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap.

HIF-1 Alpha Cell Based ELISA Kit

CBA-281 Cell Biolabs 96 assays 734.4 EUR
Description: Cell Biolabs? HIF-1 Cell Based ELISA Kit is an immunoassay developed for rapid detection of HIF-1 Alpha in fixed cells. Cells on a microplate are stimulated for HIF-1 Alpha stabilization, fixed, permeabilized, and then neutralized in the well. HIF-1 Alpha is then detected with an anti-HIF-1 alpha antibody followed by an HRP conjugated secondary antibody. Each kit provides sufficient reagents to perform up to a total of 96 assays and can detect HIF-1 Alpha from human, mouse, or rat.

CytoSelect™ MTT Cell Proliferation Assay

CBA-252 Cell Biolabs 960 assays 320 EUR

Radius™ 24-Well Cell Migration Assay

CBA-125 Cell Biolabs 24 assays 425 EUR

Radius™ 24-Well Cell Migration Assay

CBA-125-5 Cell Biolabs 5 x 24 assays 1820 EUR

Radius™ 96-Well Cell Migration Assay

CBA-126 Cell Biolabs 96 assays 495 EUR

Radius™ 96-Well Cell Migration Assay

CBA-126-5 Cell Biolabs 5 x 96 assays 2095 EUR

Radius™ 48-Well Cell Migration Assay

CBA-5037 Cell Biolabs 48 assays 445 EUR

Radius™ 48-Well Cell Migration Assay

CBA-5037-5 Cell Biolabs 5 x 48 assays 1895 EUR

CytoSelect™ BrdU Cell Proliferation ELISA Kit

CBA-251 Cell Biolabs 96 assays 455 EUR

CytoSelect Cell Proliferation Assay Reagent (Fluorometric)

CBA-250 Cell Biolabs 10 mL 490.8 EUR
Description: Cell Biolabs? CytoSelect Cell Proliferation Assay Reagent (Fluorometric) provides a fluorometric format for measuring and monitoring cell proliferation. Cells can be plated and then treated with compounds or agents that affect proliferation.  Cells are then incubated with the proliferation reagent.  Upon entering metabolically active live cells, the non-fluorescent proliferation reagent is converted into a bright red fluorescent form. An increase in cell proliferation is accompanied by increased fluorescent signal, while a decrease in cell proliferation (and signal) can indicate the toxic effects of compounds or suboptimal culture conditions.  The assay principles are basic and can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues.  This cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells. The kit contains sufficient reagents for the evaluation of 960 assays in ten 96-well plates or 192 assays in eight 24-well plates.

CytoSelect™ 96-well Cell Transformation Assay

CBA-130 Cell Biolabs 96 assays 640 EUR

CytoSelect™ 96-well Cell Transformation Assay

CBA-130-5 Cell Biolabs 5 x 96 assays 2695 EUR

CytoSelect™ Cell Viability and Cytotoxicity Assay

CBA-240 Cell Biolabs 96 assays 305 EUR

Platinum-E Retroviral Packaging Cell Line, Ecotropic

RV-101 Cell Biolabs 1 vial 770 EUR

Platinum-GP Retroviral Packaging Cell Line, Pantropic

RV-103 Cell Biolabs 1 vial 770 EUR

CytoSelect™ 24-Well Cell Co-Culture System

CBA-160 Cell Biolabs 24 assays 365 EUR

CytoSelect™ 24-Well Cell Co-Culture System

CBA-160-5 Cell Biolabs 5 x 24 assays 1585 EUR

Total Protein - Murine Embryonic Stem Cell Line D3

CBA-305 Cell Biolabs 500 ?g 414 EUR
Description:
  • Isolated from mouse ES-D3 cell line
  • Presented as 500 µg at 1 mg/mL in NP-40 Solubilization Buffer

CytoSelect 24-well Laminin Cell Invasion, Colorimetric

CBA-110-LN Cell Biolabs 12 assays 714 EUR
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with Laminin.

Platinum-A Retroviral Packaging Cell Line, Amphotropic

RV-102 Cell Biolabs 1 vial 770 EUR

CytoSelect™ 48-Well Cell Contraction Assay Kit

CBA-5021 Cell Biolabs 48 assays 575 EUR

CytoSelect 384-well Cell Transformation Assay, Fluorometric

CBA-145 Cell Biolabs 384 assays 1208.4 EUR
Description: Our CytoSelect 384-Well Cell Transformation Assay uses a modified soft agar 3D matrix to support the formation of colonies by neoplastic cells. Quantitation of cell transformation is performed on a fluorescence plate reader.

CytoSelect 384-well Cell Transformation Assay, Fluorometric

CBA-145-5 Cell Biolabs 5 x 384 assays 4681.2 EUR
Description: Our CytoSelect 384-Well Cell Transformation Assay uses a modified soft agar 3D matrix to support the formation of colonies by neoplastic cells. Quantitation of cell transformation is performed on a fluorescence plate reader.

CytoSelect™ Cell Proliferation Assay Reagent (Colorimetric)

CBA-253 Cell Biolabs 10 mL 320 EUR

Radius 24-Well Cell Migration Assay, (Laminin Coated)

CBA-125-LN Cell Biolabs 24 assays 714 EUR
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap.

StemTAG PCR Primer Set for Stem Cell Characterization

CBA-303 Cell Biolabs 1 kit 470.4 EUR
Description: StemTAG PCR Primer Set for Stem Cell Characterization includes 7 primer pairs: Oct-4, NANOG, AFP, Flk-1, and NCAM, plus GAPDH and beta-actin as controls.

CytoSelect Clonogenic Tumor Cell Isolation Kit (5 preps)

CBA-155 Cell Biolabs 5 preps 957.6 EUR
Description: Many solid tumors contain heterogeneous populations of normal and cancerous cells. Separation of these cell populations is key to an accurate assessment of the true genotypic and phenotypic differences between normal and tumor cells. Our CytoSelect Clonogenic Tumor Cell Isolation Kit uses a proprietary semisolid agar medium to facilitate formation of colonies by cells from solid tumors. Colonies are grown in either a 6-well plate or a 35mm culture dish. These colonies are isolated away from single (i.e. normal) cells by size filtration. The viable cells from these colonies can be easily recovered for further analysis.

Radius 24-Well Cell Migration Assay, (Fibronectin Coated)

CBA-125-FN Cell Biolabs 24 assays 714 EUR
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap.

CytoSelect™ 24-well Collagen Cell Invasion, Colorimetric

CBA-110-COL Cell Biolabs 12 assays 535 EUR

Radius 24-Well Cell Migration Assay, (ECM Array Coated)

CBA-125-ECM Cell Biolabs 24 wells 838.8 EUR
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap.

CytoSelect Proliferating Cell Nuclear Antigen (PCNA) ELISA Kit

CBA-254 Cell Biolabs 96 assays 672 EUR
Description: Cell Biolabs? CytoSelect Proliferating Cell Nuclear Antigen (PCNA) ELISA Kit is an enzyme immunoassay developed for the detection and quantitation of PCNA from nuclear and whole cell extracts.  The kit detects PCNA from mouse, rat and human, and has a detection sensitivity limit of 12.5 ng/mLPCNA.  Each kit provides sufficient reagents to perform up to 96 assays including standard curve and unknown samples. 

CytoSelect 48-well Cell Adhesion Assay (Laminin, Colorimetric)

CBA-056 Cell Biolabs 48 assays 512.4 EUR
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Laminin.

CytoSelect 48-well Cell Adhesion Assay (Laminin, Fluorometric)

CBA-057 Cell Biolabs 48 assays 553.2 EUR
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Laminin.

CytoSelect 24-well Laminin Cell Invasion Assay, Fluorometric

CBA-111-LN Cell Biolabs 12 assays 714 EUR
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with Laminin.

CytoSelect 96-well Laminin Cell Invasion Assay, Fluorometric

CBA-112-LN Cell Biolabs 96 assays 908.4 EUR
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect 96-Well Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 96-well plates on a fluorescence plate reader. Inserts are precoated on the top of the membrane with Laminin.

CytoSelect 48-well Cell Adhesion Assay (Fibrinogen, Colorimetric)

CBA-058 Cell Biolabs 48 assays 512.4 EUR
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Fibrinogen.

CytoSelect 48-well Cell Adhesion Assay (Fibrinogen, Fluorometric)

CBA-059 Cell Biolabs 48 assays 553.2 EUR
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Fibrinogen.

CytoSelect™ 96-well Phagocytosis Assay (Red Blood Cell)

CBA-220 Cell Biolabs 96 assays 540 EUR

Radius™ 24-Well Cell Migration Assay, (Collagen I Coated)

CBA-125-COL Cell Biolabs 24 assays 520 EUR

CytoSelect™ 24-well Collagen Cell Invasion Assay, Fluorometric

CBA-111-COL Cell Biolabs 12 assays 535 EUR

CytoSelect™ 96-well Collagen Cell Invasion Assay, Fluorometric

CBA-112-COL Cell Biolabs 96 assays 705 EUR

CytoSelect Clonogenic Tumor Cell Isolation Kit (5 x 5 preps)

CBA-155-5 Cell Biolabs 25 preps 3894 EUR
Description: Many solid tumors contain heterogeneous populations of normal and cancerous cells. Separation of these cell populations is key to an accurate assessment of the true genotypic and phenotypic differences between normal and tumor cells. Our CytoSelect Clonogenic Tumor Cell Isolation Kit uses a proprietary semisolid agar medium to facilitate formation of colonies by cells from solid tumors. Colonies are grown in either a 6-well plate or a 35mm culture dish. These colonies are isolated away from single (i.e. normal) cells by size filtration. The viable cells from these colonies can be easily recovered for further analysis.

CytoSelect™ 48-well Cell Adhesion Assay (Fibronectin, Colorimetric)

CBA-050 Cell Biolabs 48 assays 370 EUR

CytoSelect™ 48-well Cell Adhesion Assay (Fibronectin, Fluorometric)

CBA-051 Cell Biolabs 48 assays 400 EUR

CytoSelect™ 24-well Cell Invasion (Basement Membrane), Fluorometric

CBA-111 Cell Biolabs 12 assays 535 EUR

CytoSelect™ 24-well Cell Migration Assay (8 μm), Colorimetric

CBA-100 Cell Biolabs 12 assays 480 EUR

CytoSelect™ 24-well Cell Migration Assay (8 μm), Colorimetric

CBA-100-5 Cell Biolabs 5 x 12 assays 2180 EUR

CytoSelect™ 24-well Cell Migration Assay (8 μm), Fluorometric

CBA-101 Cell Biolabs 12 assays 480 EUR

CytoSelect™ 24-well Cell Migration Assay (8 μm), Fluorometric

CBA-101-5 Cell Biolabs 5 x 12 assays 2180 EUR

CytoSelect™ 24-well Cell Migration Assay (5 μm), Fluorometric

CBA-102 Cell Biolabs 12 assays 480 EUR

CytoSelect™ 24-well Cell Migration Assay (5 μm), Fluorometric

CBA-102-5 Cell Biolabs 5 x 12 assays 2180 EUR

CytoSelect™ 24-well Cell Migration Assay (3 μm), Fluorometric

CBA-103 Cell Biolabs 12 assays 480 EUR

CytoSelect™ 24-well Cell Migration Assay (3 μm), Fluorometric

CBA-103-5 Cell Biolabs 5 x 12 assays 2180 EUR

CytoSelect™ 96-well Cell Migration Assay (3 μm), Fluorometric

CBA-104 Cell Biolabs 96 assays 580 EUR

CytoSelect™ 96-well Cell Migration Assay (3 μm), Fluorometric

CBA-104-5 Cell Biolabs 5 x 96 assays 2535 EUR

CytoSelect™ 96-well Cell Migration Assay (5 μm), Fluorometric

CBA-105 Cell Biolabs 96 assays 580 EUR

CytoSelect™ 96-well Cell Migration Assay (5 μm), Fluorometric

CBA-105-5 Cell Biolabs 5 x 96 assays 2535 EUR

CytoSelect™ 96-well Cell Migration Assay (8 μm), Fluorometric

CBA-106 Cell Biolabs 96 assays 580 EUR

CytoSelect™ 96-well Cell Migration Assay (8 μm), Fluorometric

CBA-106-5 Cell Biolabs 5 x 96 assays 2535 EUR

CytoSelect™ 24-well Cell Migration Assay (12 μm), Colorimetric

CBA-107 Cell Biolabs 12 assays 480 EUR

CytoSelect™ 24-well Cell Migration Assay (12 μm), Fluorometric

CBA-108 Cell Biolabs 12 assays 480 EUR

CytoSelect™ 48-well Cell Adhesion Assay (ECM Array, Colorimetric)

CBA-070 Cell Biolabs 48 assays 515 EUR

CytoSelect™ 48-well Cell Adhesion Assay (ECM Array, Colorimetric)

CBA-070-5 Cell Biolabs 5 x 48 assays 2275 EUR

CytoSelect™ 48-well Cell Adhesion Assay (ECM Array, Fluorometric)

CBA-071 Cell Biolabs 48 assays 555 EUR

CytoSelect™ 48-well Cell Adhesion Assay (ECM Array, Fluorometric)

CBA-071-5 Cell Biolabs 5 x 48 assays 2430 EUR

CytoSelect™ 48-well Cell Adhesion Assay (Collagen I, Colorimetric)

CBA-052 Cell Biolabs 48 assays 370 EUR

CytoSelect™ 48-well Cell Adhesion Assay (Collagen I, Fluorometric)

CBA-053 Cell Biolabs 48 assays 400 EUR

CytoSelect™ 48-well Cell Adhesion Assay (Collagen IV, Colorimetric)

CBA-060 Cell Biolabs 48 assays 370 EUR

CytoSelect™ 48-well Cell Adhesion Assay (Collagen IV, Fluorometric)

CBA-061 Cell Biolabs 48 assays 400 EUR

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC802403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC802403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC812403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC812403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC052403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405M conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC052403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405M conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC432403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF543 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC432403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF543 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC552403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF555 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC552403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF555 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC702403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF770 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC702403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF770 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC612403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF660R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC612403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF660R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCH2403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCH2403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCP2403-250 Biotium 250uL 472.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), PerCP conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCR2403-250 Biotium 250uL 472.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), RPE conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCA2403-250 Biotium 250uL 472.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), APC conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCAP2403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCAP2403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNUB2403-50 Biotium 50uL 486 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), 1mg/mL

CytoSelect™ 24-well Cell Invasion Assay (Basement Membrane), Colorimetric

CBA-110 Cell Biolabs 12 assays 535 EUR

CytoSelect™ 96-well Cell Invasion Assay (Basement Membrane), Fluorometric

CBA-112 Cell Biolabs 96 assays 705 EUR

CytoSelect™ 96-Well Hematopoietic Colony Forming Cell Assay (96 assays)

CBA-320 Cell Biolabs 96 assays 440 EUR

CytoSelect™ 24-Well Cell Contraction Assay Kit (Floating Matrix Model)

CBA-5020 Cell Biolabs 24 assays 495 EUR

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody - With BSA and Azide, Clone: NK/804

AMM00762G Leading Biology 0.05mg 475.2 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone NK/804. This antibody is applicable in IHC, IF

CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), FN-coated, Colorimetric

CBA-100-FN Cell Biolabs 12 assays 505 EUR

CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), FN-coated, Fluorometric

CBA-101-FN Cell Biolabs 12 assays 505 EUR

CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), COL-coated, Colorimetric

CBA-100-COL Cell Biolabs 12 assays 505 EUR

CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), COL-coated, Fluorometric

CBA-101-COL Cell Biolabs 12 assays 505 EUR

CytoSelect 24-Well Cell Migration Assay (5 µm, Fluorometric Format), Trial Size

CBA-102-T Cell Biolabs 4 assays 358.8 EUR
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 5 µm pore size is ideal for monocytes / macrophages.

Plasma Cell Marker Antibody

V9116-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma.

Plasma Cell Marker Antibody

V9116-20UG NSJ Bioreagents 20 ug 186.15 EUR
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma.

Plasma Cell Marker Antibody

V9116IHC-7ML NSJ Bioreagents 7 ml 424.15 EUR
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma.

Plasma Cell Marker Antibody

V9116SAF-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma.

Plasma Cell Marker Antibody

V2360-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues.

Plasma Cell Marker Antibody

V2360-20UG NSJ Bioreagents 20 ug 186.15 EUR
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues.

Plasma Cell Marker Antibody

V2360IHC-7ML NSJ Bioreagents 7 ml 424.15 EUR
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues.

Plasma Cell Marker Antibody

V2360SAF-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues.

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody - With BSA and Azide, Clone: NK-1

AMM00753G Leading Biology 0.05mg 475.2 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone NK-1. This antibody is applicable in IHC, IF

CytoSelect™ 96-Well Hematopoietic Colony Forming Cell Assay (5 x 96 assays)

CBA-320-5 Cell Biolabs 5 x 96 assays 1885 EUR

Myeloid Cell Marker Antibody

V9118-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: SPM298 Ab reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. Markers of myeloid cells are useful in the identification of different levels of cellular differentiation.

Myeloid Cell Marker Antibody

V9118-20UG NSJ Bioreagents 20 ug 186.15 EUR
Description: SPM298 Ab reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. Markers of myeloid cells are useful in the identification of different levels of cellular differentiation.

Myeloid Cell Marker Antibody

V9118IHC-7ML NSJ Bioreagents 7 ml 424.15 EUR
Description: SPM298 Ab reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. Markers of myeloid cells are useful in the identification of different levels of cellular differentiation.

Myeloid Cell Marker Antibody

V9118SAF-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: SPM298 Ab reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. Markers of myeloid cells are useful in the identification of different levels of cellular differentiation.

Myeloid Cell Marker Antibody

V2356-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: This antibody recognizes a 183kDa protein with DNA-binding characteristics, which is identified as a myeloid cell specific antigen. Clone BM-1 antibody reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. This type of marker is useful in the identification of different levels of cellular differentiation. BM-1 and BM-2 antibodies react with early precursor and mature forms of human myeloid cells. This mAb is useful in the identification of myelogenous leukemias, distinguishing granulocytic sarcomas from lymphoid malignancies and also in the study of differentiation and transformation of human myeloid cells. The biological function of the marker protein is not clear, although it has been proposed that it may play a role in cell differentiation.

Myeloid Cell Marker Antibody

V2356-20UG NSJ Bioreagents 20 ug 186.15 EUR
Description: This antibody recognizes a 183kDa protein with DNA-binding characteristics, which is identified as a myeloid cell specific antigen. Clone BM-1 antibody reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. This type of marker is useful in the identification of different levels of cellular differentiation. BM-1 and BM-2 antibodies react with early precursor and mature forms of human myeloid cells. This mAb is useful in the identification of myelogenous leukemias, distinguishing granulocytic sarcomas from lymphoid malignancies and also in the study of differentiation and transformation of human myeloid cells. The biological function of the marker protein is not clear, although it has been proposed that it may play a role in cell differentiation.

FGDs showed that the need to hide from others to avoid sharing and undesirable effects were other constraints on RUF feeding.This study revealed several factors reducing the acceptability and adherence to RUF therapy based on WHO guidelines in HIV-infected adolescents.

Tailoring prescription guidance and empowering young patients in their care are crucial levers for improving the acceptability of RUF-based therapy in routine care.ClinicalTrials.gov identifier